Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FLT1 | P17948 | 8/20 | 1.00 |
| ▸ | FGFR1 | P11362 | 6/20 | 1.00 |
| ▸ | KDR | P35968 | 11/20 | 0.75 |
| ▸ | FLT4 | P35916 | 3/20 | 0.73 |
| ▸ | FGFR2 | P21802 | 1/20 | 0.73 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.73 |
| ▸ | FGFR3 | P22607 | 1/20 | 0.73 |
| ▸ | SRC | P12931 | 2/20 | 0.54 |
| ▸ | EGFR | P00533 | 7/20 | 0.54 |
| ▸ | RET | P07949 | 3/20 | 0.50 |
| ▸ | KIF5B | P33176 | 3/20 | 0.50 |
| ▸ | GAK | O14976 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6431098 | 0.99 | FLT1 (0.98) | FLT1FGFR1KDRFLT4FGFR2 | |
| SCHEMBL6437903 | 0.92 | FLT1 (0.84) | FLT1FGFR1KDRFLT4FGFR2 | |
| Hydrochloric Acid SCHEMBL6435465 | 0.91 | FLT1 (0.83) | FLT1FGFR1KDRFLT4FGFR2 | |
| SCHEMBL6436401 | 0.90 | FLT1 (0.82) | FLT1FGFR1KDRFLT4FGFR2 | |
| SCHEMBL6430841 | 0.89 | FLT1 (0.80) | FLT1FGFR1KDRFLT4FGFR2 | |
| Hydrochloric Acid SCHEMBL6431121 | 0.89 | FLT1 (0.80) | FLT1FGFR1KDRFLT4FGFR2 | |
| Hydrochloric Acid SCHEMBL6431075 | 0.88 | FLT1 (0.79) | FLT1FGFR1KDRFLT4FGFR2 | |
| SCHEMBL6433880 | 0.86 | FLT1 (0.75) | FLT1FGFR1KDRFLT4FGFR2 | |
| SCHEMBL6430998 | 0.86 | FLT1 (0.75) | FLT1FGFR1KDRFLT4FGFR2 | |
| SCHEMBL6431147 | 0.86 | FLT1 (0.75) | FLT1FGFR1KDRFLT4FGFR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0929526-B1 | QINOLINE DERIVATIVES INHIBITING THE EFFECT OF GROWTH FACTORS SUCH AS VEGF | ASTRAZENECA AB (SE) | 2005-07-27 | — | — | EP | claimed |
| US-6809097-B1 | ANTIANGIOGENIC AND/OR VASCULAR PERMEABILITY | ZENECA LIMITED (GB) | 2004-10-26 | — | — | US | claimed |
| EP-0929526-A1 | QINOLINE DERIVATIVES INHIBITING THE EFFECT OF GROWTH FACTORS SUCH AS VEGF | ZENECA LIMITED (GB) | 1999-07-21 | — | — | EP | claimed |
| WO-1998013350-A1 | QINOLINE DERIVATIVES INHIBITING THE EFFECT OF GROWTH FACTORS SUCH AS VEGF | ZENECA LIMITED (GB) | 1998-04-02 | — | — | WO | claimed |
| EP-0929526-B1 | QINOLINE DERIVATIVES INHIBITING THE EFFECT OF GROWTH FACTORS SUCH AS VEGF | ASTRAZENECA AB (SE) | 2005-07-27 | — | — | EP | disclosed |
| US-6809097-B1 | ANTIANGIOGENIC AND/OR VASCULAR PERMEABILITY | ZENECA LIMITED (GB) | 2004-10-26 | — | — | US | disclosed |
| EP-0929526-A1 | QINOLINE DERIVATIVES INHIBITING THE EFFECT OF GROWTH FACTORS SUCH AS VEGF | ZENECA LIMITED (GB) | 1999-07-21 | — | — | EP | disclosed |
| WO-1998013350-A1 | QINOLINE DERIVATIVES INHIBITING THE EFFECT OF GROWTH FACTORS SUCH AS VEGF | ZENECA LIMITED (GB) | 1998-04-02 | — | — | WO | disclosed |